Suppr超能文献

骨肉瘤的系列铊-201闪烁扫描术。与术前化疗后肿瘤坏死的相关性。

Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.

作者信息

Rosen G, Loren G J, Brien E W, Ramana L, Waxman A, Lowenbraun S, Eckardt J J, Eilber F, Menendez L, Mirra J M

机构信息

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.

出版信息

Clin Orthop Relat Res. 1993 Aug(293):302-6.

PMID:8393392
Abstract

In 27 patients with extremity lesions (24 osteosarcoma, three malignant fibrous histiocytoma), a notable decrease in thallium-201 uptake was correlated with a good response to preoperative chemotherapy of the primary tumor. A good response is indicated by a greater than 95% tumor necrosis. Serial quantitative thallium-201 uptake of malignant bone tumors in patients receiving preoperative chemotherapy therefore can accurately predict a good histologic response and prognosis. Serial thallium scintigraphy can furthermore identify poor responses within two weeks after the initiation of treatment, or can prompt an early change in preoperative chemotherapy and facilitate limb salvage surgery.

摘要

在27例肢体病变患者(24例骨肉瘤,3例恶性纤维组织细胞瘤)中,201铊摄取量显著降低与原发肿瘤术前化疗的良好反应相关。良好反应表现为肿瘤坏死率大于95%。因此,接受术前化疗患者的恶性骨肿瘤的系列定量201铊摄取可以准确预测良好的组织学反应和预后。系列铊闪烁扫描还可以在治疗开始后两周内识别不良反应,或促使术前化疗尽早改变并有利于保肢手术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验